Cellular Dynamics International announced today it signed an agreement with the Jain Foundation to create five induced pluripotent stem cell (iPSC) lines from patients with muscular dystrophies for the eventual purpose of drug…
Researchers at the University of Wisconsin School of Medicine and Public Health announced this week that they discovered an event that controls the production of blood stem cells. According to a release,…
The U.S. Patent and Trademark Office on Monday issued Cellular Dynamics International a patent that relates to the method by which adult tissue cells are reprogrammed into induced pluripotent stem (iPS)…
Congress needs to invest in our intellectual infrastructure. That was what U.S. Representative Ron Kind told the audience at the BioForward monthly meeting–a Forward Festival event–Tuesday at the MGE Innovation…
Genetic defects may be repaired through a technique created by researchers from the Morgridge Institute for Research and Northwestern University, the organizations announced this week. In an article published in the Proceedings of the…
Cellular Dynamics International‘s initial public offering raised $43 million, after deducting underwriting discounts and commissions, the company announced today. Sales of the stock (ICEL) began on July 25. According to a…
Cellular Dynamics International, Inc., will price its 3,846,000 shares of common stock at $12 per share, the company announced today. The shares will begin trading on Thursday on the Nasdaq Global…
The Wisconsin Alumni Research Foundation (WARF) issued the fourth most university biotechnology patents in the United States and Europe between 2008 and 2012, according to Bioentrepreneur. Data in Bioentrepreneur said…
For years, scientists have used animals to imitate human diseases. Now scientists are using the induced pluripotent stem cell (iPS cell) that develops specialized cells as functional models of human…
Cellular Dynamics International announced this week that it has filed with the SEC for an initial public offering of common stock. The company founded by stem cell pioneer James Thomson develops…
